Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,872,508
+$3,525,176 QoQ
Shares Held
8,231
+19.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,266
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. LLY ranks #1 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,872,508 | 8,231 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $6,347,332 | 6,901 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,445,910 | 7,859 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $4,846,576 | 6,352 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,485,278 | 4,471 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,508,465 | 4,248 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,925,108 | 3,789 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,009,538 | 3,397 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $2,844,703 | 3,142 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,549,374 | 3,277 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,893,324 | 3,248 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $1,650,063 | 3,072 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,481,038 | 3,158 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,024,421 | 2,983 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,131,543 | 3,093 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $780,566 | 2,414 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $751,240 | 2,317 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $663,519 | 2,317 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $556,859 | 2,016 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $486,591 | 2,106 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $514,583 | 2,242 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $469,105 | 2,511 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $383,266 | 2,270 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $307,437 | 2,077 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $307,016 | 1,870 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $259,406 | 1,870 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||